DrugDashboards

Desipramine Hydrochloride

Desipramine Hydrochloride · DESIPRAMINE HYDROCHLORIDE 25 mg/1 · Tablet, Film Coated · Oral · Alembic Pharmaceuticals Limited

NDC 46708-0316-30 · 30 TABLET, FILM COATED in 1 BOTTLE · ANDA · View full market →

The short version

Just 3 companies supply this market — thin enough that a single exit would be felt immediately. Historically, drugs in this position went on to a new shortage within 90 days about 0.3% of the time — roughly 2× the typical drug (0.1%).

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

90-day shortage risk (model v2)

0.3%chance of a new FDA shortage posting for desipramine hydrochloride (oral solid) in the next 90 days

6 Class I/II recall(s) in 12 months · OAI inspection at a producing facility (24 months) · sole-source market

For scale: the typical drug’s chance is about 0.1% — this one is 2× that.

Backtested statistical model over the whole market, not this package alone. Model details →

Where it's made

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Regulatory

Application
ANDA209785
TE code
AB
Approval date
Jul 7, 2021
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Desipramine Hydrochloride (Tablet, Film Coated)

LabelerStrengthFirst seenLast seen
Actavis Pharma, Inc.DESIPRAMINE HYDROCHLORIDE 150 mg/1Jul 15, 2026Sep 2, 2026
Actavis Pharma, Inc.DESIPRAMINE HYDROCHLORIDE 75 mg/1Jul 15, 2026Sep 2, 2026
Actavis Pharma, Inc.DESIPRAMINE HYDROCHLORIDE 25 mg/1Jul 15, 2026Sep 2, 2026
Actavis Pharma, Inc.DESIPRAMINE HYDROCHLORIDE 100 mg/1Jul 15, 2026Sep 2, 2026
Actavis Pharma, Inc.DESIPRAMINE HYDROCHLORIDE 10 mg/1Jul 15, 2026Sep 2, 2026
Actavis Pharma, Inc.DESIPRAMINE HYDROCHLORIDE 50 mg/1Jul 15, 2026Sep 2, 2026
Alembic Pharmaceuticals Inc.DESIPRAMINE HYDROCHLORIDE 10 mg/1Jul 15, 2026Sep 2, 2026
Alembic Pharmaceuticals Inc.DESIPRAMINE HYDROCHLORIDE 100 mg/1Jul 15, 2026Sep 2, 2026
Alembic Pharmaceuticals Inc.DESIPRAMINE HYDROCHLORIDE 150 mg/1Jul 15, 2026Sep 2, 2026
Alembic Pharmaceuticals Inc.DESIPRAMINE HYDROCHLORIDE 25 mg/1Jul 15, 2026Sep 2, 2026
Alembic Pharmaceuticals Inc.DESIPRAMINE HYDROCHLORIDE 50 mg/1Jul 15, 2026Sep 2, 2026
Alembic Pharmaceuticals Inc.DESIPRAMINE HYDROCHLORIDE 75 mg/1Jul 15, 2026Sep 2, 2026
Alembic Pharmaceuticals LimitedDESIPRAMINE HYDROCHLORIDE 100 mg/1Jul 15, 2026Sep 2, 2026
Alembic Pharmaceuticals LimitedDESIPRAMINE HYDROCHLORIDE 75 mg/1Jul 15, 2026Sep 2, 2026
Alembic Pharmaceuticals LimitedDESIPRAMINE HYDROCHLORIDE 50 mg/1Jul 15, 2026Sep 2, 2026
Alembic Pharmaceuticals LimitedDESIPRAMINE HYDROCHLORIDE 150 mg/1Jul 15, 2026Sep 2, 2026
Alembic Pharmaceuticals LimitedDESIPRAMINE HYDROCHLORIDE 10 mg/1Jul 15, 2026Sep 2, 2026
Alembic Pharmaceuticals LimitedDESIPRAMINE HYDROCHLORIDE 25 mg/1Jul 15, 2026Sep 2, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Desipramine Hydrochloride — NDC 46708-0316-30," retrieved September 3, 2026, https://drugdashboards.com/drug/46708031630.

Free to cite with attribution — see how the data is put together.